Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
11.41
+0.23 (2.06%)
Dec 20, 2024, 4:00 PM EST - Market closed
Evolent Health Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$25.90
Upside
+126.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $45 → $15 | Buy | Maintains | $45 → $15 | +31.46% | Nov 22, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $34 → $28 | Buy | Maintains | $34 → $28 | +145.40% | Nov 18, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $33 → $21 | Strong Buy | Maintains | $33 → $21 | +84.05% | Nov 13, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +75.28% | Nov 12, 2024 |
| Barclays | Barclays | Buy Maintains $39 → $19 | Buy | Maintains | $39 → $19 | +66.52% | Nov 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $45 → $34 | Buy | Maintains | $45 → $34 | +197.98% | Nov 8, 2024 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $16 | Buy → Hold | Downgrades | $16 | +40.23% | Nov 8, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +189.22% | Oct 29, 2024 |
| Keybanc | Keybanc | Buy Initiates $35 | Buy | Initiates | $35 | +206.75% | Oct 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $42 | Buy | Reiterates | $42 | +268.10% | Oct 8, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +189.22% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $42 | Buy | Reiterates | $42 | +268.10% | Aug 26, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $36 → $45 | Buy | Maintains | $36 → $45 | +294.39% | Aug 19, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $34 → $31 | Buy | Maintains | $34 → $31 | +171.69% | Aug 9, 2024 |
| Truist Securities | Truist Securities | Hold → Strong Buy Upgrades $28 → $33 | Hold → Strong Buy | Upgrades | $28 → $33 | +189.22% | Aug 9, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $42 | Buy | Reiterates | $42 | +268.10% | Jul 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.